Skip to main content
OpenTrials
Completed

NCT Number: NCT06288867

A 12 Months Prospective Study Comparing Functional Outcome Scores in Hip Arthroscopic Labral Repair Versus Debridement

This study aims to address hip labral tears and compare arthroscopic labral repair versus debridement in non-athletic population aged 20 to 50 years old, including both sexes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hip Injuries Acetabular Labral Tear Femoracetabular Impingement Femoro Acetabular Impingement Joint Diseases Musculoskeletal Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Wounds and Injuries

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ain Shams University

Cairo, Egypt

About this study

Hip arthroscopy will be performed with the patient under general anesthesia. The patient will be placed in supine position, and traction and joint access will be controlled by fluoroscopy. An anterolateral portal and an inferior mid-anterior portal will be used. Any labral, chondral, and/or bony pathology (cam or pincer) will be treated. Labral tears may be debrided or repaired. Labral repairs will be secured with suture anchors.

Patient's functions will be evaluated preoperatively and postoperatively at 1, 3 and 6 months and 1 year and at the last follow-up using the Harris Hip Score (HHS), visual analog score (VAS), Hip Outcome Score Activities-Daily Living Subscale (HOS-ADL), and Sport-Specific Subscale (HOS-SSS).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sex: both sexes.
  • Age: 20 years - 50 years, non-athletes.
  • Femoroacetabular impingement (FAI) including all types (cam, pincer, and combined).

Exclusion criteria

  • Previous hip surgery.
  • Hip joint dysplasia, defined by both center edge (CE) angles <25 degrees and Acetabular Index angle >10 degrees.
  • Osteoarthritis grade >2 according to Tönnis classification.

Treatment and study plan

Arthroscopic Labral Repair

Procedure

Patients with Hip Labral tears will be treated with labral repair

Arthroscopic Labral Debridement

Procedure

Patients with Hip Labral tears will be treated with labral debridement

Primary outcomes

  1. Change from baseline in Hip Function, as measured by Hip Outcome Score (HOS)

    Time frame: Baseline, 1 year

    The HOS is a patient-completed measure that consists of an "Activities of Daily Living" subscale (17 scored items) and a "Sports" subscale (9 scored items) in which the response options are presented as 5-point Likert scales (Scores 0-4). Scores for each subscale range from 0% (least function) to 100% (most function).The highest potential score is 68, a higher score represents a higher level of physical function for both the ADL and sports subscales

  2. Change from baseline in Hip Function, as measured by Harris Hip Score (HHS)

    Time frame: Baseline, 1 year

    <70 (poor result), 70-79 (fair result), 80-89 (good result) and >90 (excellent result)

  3. Change from baseline in Pain, as measured by the Visual Analogue Scale (VAS)

    Time frame: Baseline, 1 year

    Scores are measured on a 100 mm VAS. The VAS ranges from 0 to 100 with 0 indicating no pain, and higher scores indicating greater pain

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Arthroscopic Labral Repair Versus Debridement In Hip Labral Tears: A Prospective Comparative Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 1, 2024
Registry last updated
Jul 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.